Business

Novo Nordisk Faces Generics Challenge

Updated 2026-05-07 18:50 UTC 1 source Negative

Novo Nordisk faces potential revenue decline as the first generics of its semaglutide drug, used in Ozempic and Wegovy, enter the Canadian market.

Coverage timeline — 1 article

CNBC

Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk

New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.

2026-05-07 18:39 UTC